Brain-derived neurotrophic-factor (BDNF), the most abundant of the neurotrophins in the
brain, has been implicated in both major depression and cognitive function. This study …

Preclinical studies have shown that brain‐derived neurotrophic factor (BDNF) may be involved
in both antidepressant action and the pathophysiology of major depressive disorder (MDD…

Schizophrenia has been primarily associated with dopamine dysfunction, and treatments
have been developed that target the dopamine pathway in the central nervous system. …

Objective Increasing evidence supports reciprocal communication between the enteric and
the central nervous system in disease, termed the ‘gut–brain axis’. Recent findings suggest a …

Major depressive disorder (MDD), which is a leading psychiatric illness across the world,
severely affects quality of life and causes an increased incidence of suicide. Evidence from …

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin growth factor family,
has been implicated in both mood disorders and suicidal behavior. This study has …

Monoamine oxidase A (MAOA), a mitochondrial enzyme involved in the degradation of biogenic
amines, may be implicated in the pathogenesis of major depressive disorder (MDD) and …

The first brain-wide voxel-level resting state functional connectivity neuroimaging analysis
of depression is reported, with 421 patients with major depressive disorder and 488 control …

The nonlinear properties of spontaneous fluctuations in blood oxygen level-dependent (BOLD)
signals remain unexplored. We test the hypothesis that complexity of BOLD activity is …

Full article: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for
treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. …